Artiva Biotherapeutics, Inc. ARTV Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artiva Biotherapeutics, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artiva Biotherapeutics, Inc.'s operating lease ROU assets?
- Artiva Biotherapeutics, Inc. (ARTV) reported operating lease ROU assets of $9.88M in Q1 2026.
- How has Artiva Biotherapeutics, Inc.'s operating lease ROU assets changed year-over-year?
- Artiva Biotherapeutics, Inc.'s operating lease ROU assets decreased by 26.7% year-over-year, from $13.48M to $9.88M.
- What is the long-term trend for Artiva Biotherapeutics, Inc.'s operating lease ROU assets?
- Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s operating lease ROU assets has grown at a -20.2% compound annual growth rate (CAGR), from $16.55M to $10.53M.
- What does operating lease ROU assets mean?
- This asset represents the company's right to use a leased item, such as office space or data center facilities, over the lease term. It is recognized under modern accounting standards to reflect the financial commitment of long-term operating leases. It provides visibility into the company's fixed operational footprint.